An Open-label, Non-randomized, Fixed Sequence Study Assessing the Pharmacokinetics of AZD7986 When Administered Alone and With Multiple Doses of Verapamil and Itraconazole or Diltiazem in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 26 Feb 2018
At a glance
- Drugs INS 1007 (Primary) ; Diltiazem; Itraconazole; Verapamil
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 15 Apr 2016 Status changed from active, no longer recruiting to completed.
- 14 Mar 2016 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov record.
- 28 Jan 2016 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.